GIVING TUESDAY WITH MPNRF
Giving Tuesday: When America Gives as Good as it Gets. Giving Tuesday was founded in 2012 by New York’s 92nd Street Y, in partnership with… Read More »GIVING TUESDAY WITH MPNRF
MPNRF GRANTS
MPNRF GRANTS
MPNRF HONORED WITH CURE MPN HERO AWARD!
Each year for the past three years, Cure Magazine and Incyte Corporation have recognized efforts within the MPN community with their MPN Hero award. The… Read More »MPNRF HONORED WITH CURE MPN HERO AWARD!
MPNS MADE NEWS AT ASCO THIS YEAR
The American Society of Clinical Oncology has its big meeting each year in Chicago in early June. In the past solid tumor cancers have received… Read More »MPNS MADE NEWS AT ASCO THIS YEAR
MF HIKE
“With research there is hope” On August 19, 2014, Julie Libon was diagnosed with Myelofibrosis. She learned that MF is a rare blood cancer that… Read More »MF HIKE
BLOOD CANCER AWARENESS MONTH ON SOCIAL MEDIA
Tomorrow is the first day of September and this means it’s the first day of Blood Cancer Awareness Month (BCAM).All through September, share your stories… Read More »BLOOD CANCER AWARENESS MONTH ON SOCIAL MEDIA
DONATE TO VOTE ON OUR NEXT MPN RESEARCH PROJECT
You can help change your prognosis! As you know, September is Blood Cancer Awareness Month. Last year, 120 MPN patients let us know what research… Read More »DONATE TO VOTE ON OUR NEXT MPN RESEARCH PROJECT
WHAT’S NEXT FOR MPN RESEARCH?
Before there was knowledge of the JAK2 mutation, there was the MPN Research Foundation. Both the Foundation and MPN patients had the nerve to demand… Read More »WHAT’S NEXT FOR MPN RESEARCH?
CTI BIOPHARMA TO SUBMIT NEW DRUG APPLICATION FOR PACRITINIB
CTI Biopharma to submit NDA for Pacritinib September 23, 2015CTI BioPharma Corp. today announced their plan to submit a new drug application (NDA) to the… Read More »CTI BIOPHARMA TO SUBMIT NEW DRUG APPLICATION FOR PACRITINIB
CRAFTING THE MPN ENVIRONMENT
The World Orphan Drug Congress recently put out an independent study of the most researched rare diseases. We were shocked to see that the MPNs (MPDs on… Read More »CRAFTING THE MPN ENVIRONMENT